- The Gel-Melbourne OA shoe was launched on the Australian market in 2012
- Partnership between ASICS Oceania and Centre for Health, Exercise and Sports Medicine
- A sports shoe to protect knees of adolescent girls is in development
ASICS Oceania partnered with the University of Melbourne to create the Gel-Melbourne OA, a shoe specifically designed to treat individuals with knee osteoarthritis.
The company, part of the global athletic brand ASICS, worked with University researchers to translate conceptual designs into a viable product. The Gel-Melbourne OA shoe was launched on the Australian market in 2012.
The shoe, which was designed to limit mechanical stress on knee joints, provides an accessible and affordable option to relieve the pain associated with knee osteoarthritis.
As the most common disease of the joints, osteoarthritis is estimated to affect more than three per cent of the world’s population. Knee osteoarthritis, one of the most prevalent and costly forms of osteoarthritis in the developed world, affects 10–25 per cent of women and 5–15 per cent of men aged 60 or older. Although most often found in the elderly, knee osteoarthritis can also afflict overweight individuals.
Osteoarthritis is characterised by the breakdown of cartilage in the joints, due to stress and inflammation. The joint pain, swelling and stiffness caused by knee osteoarthritis can discourage physical activity, thus lowering quality of life and raising the risk of other medical conditions, such as diabetes, obesity and cardiovascular disease.
As the world’s population ages and obesity rates rise, the incidence of knee osteoarthritis is expected to increase. Without a cure, treatments must focus on alleviating symptoms through behavioural and biomechanical interventions.
When the foot hits the ground during walking or running, a force travels up through the lower limb to the knee. This mechanical stress causes the symptoms of knee osteoarthritis.
One method to reduce the pain associated with knee osteoarthritis is to divert or decrease this force. In the University of Melbourne’s Centre for Health, Exercise and Sports Medicine, Professors Kim Bennell and Rana Hinman, both physiotherapists, and Tim Wrigley, a biomechanist, combined their expertise to develop orthotics for this purpose.
The researchers came up with two features that change how the force travels up the leg: a midsole that is soft in the middle and stiff on the sides; and a full-length wedge that angles the foot laterally by 4–6 degrees.
Together with ASICS, the researchers incorporated those features into a shoe, at the same time overcoming problems associated with inconsistent or incorrect use of orthotics.
The research team and ASICS Oceania joined forces under a two-year Australian Research Council (ARC) Linkage Project in 2009 to study the effects of shoe design on the biomechanics of the lower limbs. Together they developed, tested and validated the researchers’ shoe concept, creating a final prototype through an iterative process of refinement.
ASICS Oceania received an exclusive license to the background intellectual property and to any intellectual property arising from the project.
Soon after the project’s completion, the ASICS Gel-Melbourne OA shoe began production and was launched on the Australian market in 2012.
A clinical trial in 2016 compared the Gel-Melbourne OA shoe to a conventional ASICS shoe in 164 people with knee osteoarthritis. Both shoes improved pain and function. Subsequent analyses of the study’s results suggested that the Gel-Melbourne OA shoe was more beneficial for trial participants with moderate to severe knee osteoarthritis.
The partnership between ASICS Oceania and the University of Melbourne is ongoing. It includes investigations into the effects of female pubertal development and ASICS footwear on knee biomechanics during sporting movements, and the effects of female hormone fluctuations on muscle properties and foot biomechanics.
A further ASICS ARC Linkage Project to develop new athletic shoes to protect the knees of adolescent girls and young women was launched in 2018 with biomechanist Associate Professor Adam Bryant, also of the University’s Centre for Health, Exercise and Sports Medicine. This ASICS shoe will be field-tested in netball, a sport with high risk of serious knee injury.